Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“As an overview, in FY17 we plan on shifting our focus to multi-site Phase 3 studies required for FDA approval of prescription use of MDMA-assisted psychotherapy for PTSD. Based on our current timeline, we anticipate submitting our New Drug Application (NDA) to the FDA in 2021.”
· Annual Financial Report Fiscal Year 2015–16 (MAPS Bulletin Winter 2016) · own post

Projections section of the FY2016 annual financial report, written by Doblin. NDA submission anticipated in 2021.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.